Am J Epidemiol 2004; 160:91-96.
Copyright © 2004 by the Johns
Hopkins Bloomberg School of Public Health
PRACTICE OF EPIDEMIOLOGY |
Indirect Estimation of Chlamydia Screening Coverage Using Public Health Surveillance Data
1 Division of STD Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
2 National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA.
Although routine screening of all sexually active adolescent females for Chlamydia trachomatis infection is recommended at least annually in the United States, no national or state-specific population-based estimates of chlamydia screening coverage are known to exist. Conclusions regarding screening coverage have often been based on surveys of health care provider or facility screening practices, but such surveys do not consider persons who do not seek care at these facilities or who seek care at more than one facility. The authors developed a method to estimate the proportion of sexually active females aged 15–19 years screened for chlamydia in 45 states and the District of Columbia by using national data on chlamydia positivity, estimates of sexual activity from the National Survey of Family Growth, and chlamydial infections reported to the Centers for Disease Control and Prevention. Because of uncertainty regarding these values and related assumptions, credibility intervals were calculated by using a Monte Carlo model. When this model was used, the median state-specific proportion of sexually active females aged 15–19 years screened in 2000 was 60% (90% credibility interval: 55, 66). These results and this method should be evaluated for their utility in guiding implementation of national and state chlamydia control programs.
adolescent; chlamydia; mass screening
Abbreviations: Abbreviations: CDC, Centers for Disease Control and Prevention; NSFG, National Survey of Family Growth.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. D. Datta, M. Sternberg, R. E. Johnson, S. Berman, J. R. Papp, G. McQuillan, and H. Weinstock Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002 Ann Intern Med, July 17, 2007; 147(2): 89 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L Cook, L. Ostergaard, S. L Hillier, P. J Murray, C.-C. H Chang, D. M Comer, R. B Ness, and for the DAISY study team Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial Sex Transm Inf, July 1, 2007; 83(4): 286 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Low, M Egger, J A C Sterne, R M Harbord, F Ibrahim, B Lindblom, and B Herrmann Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Inf, June 1, 2006; 82(3): 212 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Samoff, E. H. Koumans, L. E. Markowitz, M. Sternberg, M. K. Sawyer, D. Swan, J. R. Papp, C. M. Black, and E. R. Unger Association of Chlamydia trachomatis with Persistence of High-Risk Types of Human Papillomavirus in a Cohort of Female Adolescents Am. J. Epidemiol., October 1, 2005; 162(7): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Cook, S. L. Hutchison, L. Ostergaard, R. S. Braithwaite, and R. B. Ness Systematic Review: Noninvasive Testing for Chlamydia trachomatis and Neisseria gonorrhoeae Ann Intern Med, June 7, 2005; 142(11): 914 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D S LaMontagne, K A Fenton, S Randall, S Anderson, P Carter, and on behalf of the National Chlamydia Screening Stee Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening Sex Transm Inf, October 1, 2004; 80(5): 335 - 341. [Abstract] [Full Text] [PDF]
|
|